NasdaqCM - Nasdaq Real Time Price
USD
Gelteq Limited (GELS)
0.5488
-0.0111
(-1.98%)
At close: October 8 at 4:00:00 PM EDT
0.5260
-0.0228
(-4.15%)
Pre-Market: 4:09:10 AM EDT
Loading chart for GELS
- Previous Close
0.5599 - Open
0.5485 - Bid 0.3795 x 200
- Ask 0.6630 x 200
- Day's Range
0.5401 - 0.5501 - 52 Week Range
0.3870 - 2.0100 - Volume
17,659 - Avg. Volume
2,863,700 - Market Cap (intraday)
5.878M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4400 - Earnings Date --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 10/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
GELS
31.40%
S&P 500 (^GSPC)
13.44%
1-Year Return
GELS
57.13%
S&P 500 (^GSPC)
14.98%
3-Year Return
GELS
86.28%
S&P 500 (^GSPC)
80.23%
5-Year Return
GELS
86.28%
S&P 500 (^GSPC)
76.83%
Statistics
View MoreValuation Measures
As of 9/23/2026
-
Market Cap
6.28M
-
Enterprise Value
9.91M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
53.24
-
Price/Book (mrq)
0.62
-
Enterprise Value/Revenue
84.06
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-17.61%
-
Return on Equity (ttm)
-42.93%
-
Revenue (ttm)
471.8k
-
Net Income Avi to Common (ttm)
-7.08M
-
Diluted EPS (ttm)
-0.4400
Balance Sheet and Cash Flow
-
Total Cash (mrq)
9.35k
-
Total Debt/Equity (mrq)
36.01%
-
Levered Free Cash Flow (ttm)
-4.75M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
1.0500
0.00%
Mkt Cap
15.468M
Industry
Drug Manufacturers—Specialty & Generic
0.5780
+21.94%
Mkt Cap
5.137M
Industry
Drug Manufacturers—Specialty & Generic
5.55
+17.83%
Mkt Cap
26.444M
Industry
Drug Manufacturers—Specialty & Generic
0.8587
-2.16%
Mkt Cap
3.005M
Industry
Drug Manufacturers—Specialty & Generic
8.02
-2.43%
Mkt Cap
32.324M
Industry
Drug Manufacturers—Specialty & Generic
1.3300
0.00%
Mkt Cap
7.307M
Industry
Drug Manufacturers—Specialty & Generic
0.8350
-2.45%
Mkt Cap
88.309M
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
